Navigation Links
Mirixa Corporation Announces Key Pharmacy Network Hire

RESTON, Va., Oct. 8 /PRNewswire/ -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, announces the hiring of Cheryl Hoffer as Vice President, Pharmacy Network Management. Ms. Hoffer will lead the Mirixa Pharmacy Account Management team, supporting independent and chain pharmacies in the delivery of patient care programs. The Pharmacy Account Management team also helps expand pharmacy-based patient care opportunities, develops best practices, assists with educational and promotional activities, and provides operational support to Mirixa's pharmacy network partners.

Prior to joining Mirixa, Ms. Hoffer held marketing and managed care positions with Medicine Shoppe International, Inc. for over 24 years. She was responsible for the implementation of medication therapy management services for Medicine Shoppe® pharmacies and Medicap Pharmacy® stores. Ms. Hoffer was an active member of the National Association of Chain Drug Stores (NACDS), serving on the NACDS Policy Council, and the National Community Pharmacists Association (NCPA).

"Cheryl brings many years of pharmacy network experience to Mirixa and we're pleased to have her join our organization," said Trish Dare, Mirixa's Senior Vice President of Operations. "Her expertise will be particularly helpful as we roll out new tools in the months ahead designed to help strengthen patients' relationships with their primary care pharmacists."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit

SOURCE Mirixa Corporation

SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CEL-SCI Corporation Releases Letter to Shareholders
2. ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
3. Clinical Logistics Enters Partnership with Gentris Corporation
4. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
5. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
6. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
7. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
8. CEL-SCI Corporation Releases Letter to Shareholders
9. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
10. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
11. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
Post Your Comments:
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
Breaking Medicine News(10 mins):